These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 36963416)

  • 1. Digital health in difficult-to-treat severe asthma.
    Busse WW; Szefler SJ
    Lancet Respir Med; 2023 Jul; 11(7):578-579. PubMed ID: 36963416
    [No Abstract]   [Full Text] [Related]  

  • 2. Differentiation of adult severe asthma from difficult-to-treat asthma - Outcomes of a systematic assessment protocol.
    von Bülow A; Backer V; Bodtger U; Søes-Petersen NU; Vest S; Steffensen I; Porsbjerg C
    Respir Med; 2018 Dec; 145():41-47. PubMed ID: 30509715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and baseline characteristics of the epidemiology and natural history of asthma: Outcomes and Treatment Regimens (TENOR) study: a large cohort of patients with severe or difficult-to-treat asthma.
    Dolan CM; Fraher KE; Bleecker ER; Borish L; Chipps B; Hayden ML; Weiss S; Zheng B; Johnson C; Wenzel S;
    Ann Allergy Asthma Immunol; 2004 Jan; 92(1):32-9. PubMed ID: 14756462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predominance of Atopic Asthma in Patients with Severe or Difficult-to-Treat Asthma in the TENOR-II cohort.
    Haselkorn T; Mink D; Kianifard F; Ortiz B; Paknis B; Lecocq J; Chipps BE; Bleecker ER
    Ann Allergy Asthma Immunol; 2021 Nov; 127(5):593-595. PubMed ID: 34391902
    [No Abstract]   [Full Text] [Related]  

  • 5. The Tempest: Difficult to Control Asthma in Adolescence.
    Burg GT; Covar R; Oland AA; Guilbert TW
    J Allergy Clin Immunol Pract; 2018; 6(3):738-748. PubMed ID: 29747981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. More than a decade follow-up in patients with severe or difficult-to-treat asthma: The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) II.
    Chipps BE; Haselkorn T; Paknis B; Ortiz B; Bleecker ER; Kianifard F; Foreman AJ; Szefler SJ; Zeiger RS;
    J Allergy Clin Immunol; 2018 May; 141(5):1590-1597.e9. PubMed ID: 28797732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe and Difficult-to-Treat Asthma in Adults.
    Israel E; Reddel HK
    N Engl J Med; 2017 Sep; 377(10):965-976. PubMed ID: 28877019
    [No Abstract]   [Full Text] [Related]  

  • 8. [Severe hard-to-treat refractory asthma: the only asthma issue of the 21st century?].
    Chanez P; Humbert M
    Presse Med; 2008 Jan; 37(1 Pt 2):97-8. PubMed ID: 18055162
    [No Abstract]   [Full Text] [Related]  

  • 9. Consistently very poorly controlled asthma is associated with greater activity and school impairment in children with severe or difficult-to-treat asthma.
    Bacharier LB; Covar RA; Haselkorn T; Iqbal A; Alvarez C; Mink DR; Chen H; Zeiger RS
    J Allergy Clin Immunol Pract; 2019 Jan; 7(1):314-316. PubMed ID: 29883753
    [No Abstract]   [Full Text] [Related]  

  • 10. [Therapeutic management in severe and difficult asthma in adults].
    Małolepszy J
    Pol Merkur Lekarski; 2003 Jun; 14(84):651-2. PubMed ID: 14524293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Methotrexate may be a useful corticosteroid reducing treatment of severe asthma].
    Knarborg M; Hilberg O; Dahl R
    Ugeskr Laeger; 2014 Apr; 176(15):. PubMed ID: 25350142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Methotrexate may be a useful corticosteroid reducing treatment of severe asthma].
    Knarborg M; Hilberg O; Dahl R
    Ugeskr Laeger; 2015 Jun; 177(24):1159-63. PubMed ID: 26554054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Severe asthma: clinical and pathogenic aspects].
    Grigoraş C
    Rev Med Chir Soc Med Nat Iasi; 2003; 107(4):718-26. PubMed ID: 14756008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypes of severe asthma among children and adolescents in Brazil: a prospective study.
    de Andrade WC; Lasmar LM; Ricci Cde A; Camargos PA; Cruz ÁA
    BMC Pulm Med; 2015 Apr; 15():36. PubMed ID: 25912047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Airway inflammation in obese and nonobese patients with difficult-to-treat asthma.
    van Veen IH; Ten Brinke A; Sterk PJ; Rabe KF; Bel EH
    Allergy; 2008 May; 63(5):570-4. PubMed ID: 18394131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A guide to the pediatric patient with "difficult" asthma.
    Mazur LJ; de Ybarrondo L; Miller J
    J Pediatr Health Care; 1999; 13(6 Pt 1):284-7. PubMed ID: 10889675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors and characteristics associated with severe and difficult to treat asthma phenotype: an analysis of the ENFUMOSA group of patients based on the ECRHS questionnaire.
    Gaga M; Papageorgiou N; Yiourgioti G; Karydi P; Liapikou A; Bitsakou H; Zervas E; Koulouris NG; Holgate ST;
    Clin Exp Allergy; 2005 Jul; 35(7):954-9. PubMed ID: 16008684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EPI-ASTHMA study protocol: a population-based multicentre stepwise study on the prevalence and characterisation of patients with asthma according to disease severity in Portugal.
    Jácome C; Brito D; João C; Lopes F; Santos J; Amorim L; Barbosa MJ; Pardal M; Teixeira P; Bernardo F; Fonseca JA; Correia-de-Sousa J
    BMJ Open; 2022 Sep; 12(9):e064538. PubMed ID: 36123070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Profile of difficult to treat asthma patients referred for systematic assessment.
    Radhakrishna N; Tay TR; Hore-Lacy F; Hoy R; Dabscheck E; Hew M
    Respir Med; 2016 Aug; 117():166-73. PubMed ID: 27492528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of asthma severity on long-term asthma control.
    Sheikh SI; Ryan-Wenger NA; Pitts J; Nemastil CJ; Palacios S
    J Asthma; 2021 Jun; 58(6):725-734. PubMed ID: 32138568
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.